WAGNER CHARLES F JR 4

What Happened
Charles F. Wagner Jr., listed as EVP, CO & FO of Vertex Pharmaceuticals (VRTX), disposed of 1,744 shares on Feb 24, 2026. The shares were recorded at $485.11 each for a total value of about $846,032. The transaction is reported under code F — payment of exercise price or tax liability — which indicates shares were surrendered/withheld to cover taxes or exercise costs rather than a typical open-market sale.

Key Details

• Date of transaction: 2026-02-24
• Filing date: 2026-02-26 (appears timely based on provided dates)
• Transaction code: F — payment of exercise price or tax liability (shares withheld/surrendered)
• Shares disposed: 1,744 at $485.11 per share; total ~$846,032
• Shares owned after transaction: not specified in the provided excerpt of the filing
• No 10b5-1 plan or late-filing flag was indicated in the provided data

Context
This type of transaction is commonly a “sell to cover” or net-share settlement tied to option exercises or vesting, used solely to satisfy tax obligations. Such withholdings are routine and do not necessarily reflect the insider’s view on the company’s stock; outright purchases generally carry more informational weight for investors.